SEARCH

SEARCH BY CITATION

References

  • Bader, P., Kreyenberg, H., Henze, G.H., Eckert, C., Reising, M., Willasch, A., Barth, A., Borkhardt, A., Peters, C., Handgretinger, R., Sykora, K.W., Holter, W., Kabisch, H., Klingebiel, T. & von Stackelberg, A. (2009) Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group. Journal of Clinical Oncology, 27, 377384.
  • Coustan-Smith, E., Sancho, J., Hancock, M.L., Boyett, J.M., Behm, F.G., Raimondi, S.C., Sandlund, J.T., Rivera, G.K., Rubnitz, J.E., Ribeiro, R.C., Pui, C.H. & Campana, D. (2000) Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood, 96, 26912696.
  • Faderl, S., Gandhi, V., O’Brien, S., Bonate, P., Cortes, J., Estey, E., Beran, M., Wierda, W., Garcia-Manero, G., Ferrajoli, A., Estrov, Z., Giles, F.J., Du, M., Kwari, M., Keating, M., Plunkett, W. & Kantarjian, H. (2005) Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias. Blood, 105, 940947.
  • Hijiya, N., Gaynon, P., Barry, E., Silverman, L., Thomson, B., Chu, R., Cooper, T., Kadota, R., Rytting, M., Steinherz, P., Shen, V., Jeha, S., Abichandani, R. & Carroll, W.L. (2009) A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia. Leukemia, 23, 22592264.
  • Kurt, B., Flynn, P., Shenep, J.L., Pounds, S., Lensing, S., Ribeiro, R.C., Pui, C.H., Razzouk, B.I. & Rubnitz, J.E. (2008) Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia. Cancer, 113, 376382.
  • Locatelli, F., Testi, A.M., Bernardo, M.E., Rizzari, C., Bertaina, A., Merli, P., Pession, A., Giraldi, E., Parasole, R., Barberi, W. & Zecca, M. (2009) Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia. British Journal of Haematology, 147, 371378.
  • O’Connor, D., Sibson, K., Caswell, M., Connor, P., Cummins, M., Mitchell, C., Motwani, J., Taj, M., Vora, A., Wynn, R. & Kearns, P.R. (2011) Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia. British Journal of Haematology, 154, 482485.
  • Yamauchi, T., Nowak, B.J., Keating, M.J. & Plunkett, W. (2001) DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine. Clinical Cancer Research, 7, 35803589.